Arcotatug
Arcotatug is a CLDN18.2 targeting humanized monoclonal antibody. Arcotatug can be used for synthesis of ADC[1].
Product Specifications
Product Name Alternative
IBI-343 antibody
UNSPSC
12352203
Target
ADC Antibody; Claudin
Related Pathways
Antibody-drug Conjugate/ADC Related; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97
Molecular Weight
(145.647 kDa)
References & Citations
[1]Shen L, et al. A multiregional, randomized, controlled, open-label, phase 3 study of the anti-claudin18. 2 (CLDN18. 2) antibody-drug conjugate (ADC) arcotatug tavatecan (IBI343) in gastric or gastroesophageal junction adenocarcinoma (G/GEJA) : Trial in progress[J]. 2025.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
CLDN18
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
QP6478-ye-100ug 100ug
Recombinant S. aureus Peptide deformylase Protein, His, Yeast-100ug
Ask
View Details 
